Body Movements Analysis During Sleep in Very Premature Infants (DODOPREMA)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03432182 |
|
Recruitment Status :
Recruiting
First Posted : February 14, 2018
Last Update Posted : September 16, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Sleep | Diagnostic Test: electroencephalography | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 60 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Other |
| Official Title: | Characterization of Movements Occurring During Sleep in Very Premature Neonates: Relationship With Neurodevelopmental Outcome |
| Actual Study Start Date : | February 28, 2018 |
| Estimated Primary Completion Date : | June 30, 2023 |
| Estimated Study Completion Date : | December 31, 2025 |
| Arm | Intervention/treatment |
|---|---|
|
very premature infants
Electroencephalography allowing sleep observation
|
Diagnostic Test: electroencephalography
Sleep states definition by electroencephalograpy |
- Body movements evaluation during sleep [ Time Frame: 3 months ]number of movements observed according to sleep states
- Sleep states organization [ Time Frame: 3 months ]sleep states characterization by electroencephalography according to postmenstrual age
- Type of movements observed during sleep [ Time Frame: 3 months ]Movements characterization according to sleep states
- Neurodevelopmental outcome [ Time Frame: 3 years ]neuropsychomotor evaluation by Bayley psychometric test
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | up to 15 Days (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Infants born between 26 and 32 weeks gestation
Exclusion Criteria:
- Genetic abnormality
- Neurological pathology such as intraventricular hemorrhage > grade 2
- Any medication know for altering electroencephalography recording
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03432182
| Contact: Jean-Michel HASCOET, MD | +33 383 342 934 | j.hascoet@chru-nancy.fr | |
| Contact: Laurelia JOURDAN | +33 383 343 645 | l.jourdan@chru-nancy.fr |
| France | |
| Maternity Hospital CHRU | Recruiting |
| Nancy, France, 54035 | |
| Contact: Jean-Michel HASCOET 383342934 j.hascoet@chru-nancy.fr | |
| Responsible Party: | Jean-Michel HASCOET, Principal Investigator, Central Hospital, Nancy, France |
| ClinicalTrials.gov Identifier: | NCT03432182 |
| Other Study ID Numbers: |
2017-A02687-46 |
| First Posted: | February 14, 2018 Key Record Dates |
| Last Update Posted: | September 16, 2021 |
| Last Verified: | September 2021 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Premature infant sleep state body movement neurodevelopmental outcome |
|
Premature Birth Obstetric Labor, Premature Obstetric Labor Complications Pregnancy Complications |

